As vaccine injury and death cases pile up, Pfizer attorneys have had the brass to demand that nations pledge their sovereign assets against potential liability lawsuits, and to not apply their country’s laws against them. This is a must-read article.
Pfizer is using its position as a global vaccine provider to break down sovereign nations in order to gain genetic access to the bodies of citizens. In that all current mRNA injections are experimental gene therapy rather than true vaccines, these companies face massive civil and criminal penalties. ⁃ TN Editor
As reported by New Delhi-based World Is One News (WION),1 Pfizer is demanding countries put up sovereign assets as collateral for expected vaccine injury lawsuits resulting from its COVID-19 inoculation. In other words, it wants governments to guarantee the company will be compensated for any expenses resulting from injury lawsuits against it.
WION reports that Argentina and Brazil have rejected Pfizer’s demands. Initially, the company demanded indemnification legislation to be enacted, such as that which it enjoys in the U.S. Argentina proposed legislation that would restrict Pfizer’s financial responsibility for injuries to those resulting from negligence or malice.
Pfizer rejected the proposal. It also rejected a rewritten proposal that included a clearer definition of negligence. Pfizer then demanded the Argentinian government put up sovereign assets — including its bank reserves, military bases and embassy buildings — as collateral. Argentina refused. A similar situation occurred in Brazil. Pfizer demanded Brazil:
- “Waive sovereignty of its assets abroad in favor of Pfizer”
- Not apply its domestic laws to the company
- Not penalize Pfizer for vaccine delivery delays
- Exempt Pfizer from all civil liability for side effects
Brazil rejected Pfizer’s demands, calling them “abusive.” As noted by WION, Pfizer developed its vaccine with the help of government funding, and now it — a private company — is demanding governments hand over sovereign assets to ensure the company won’t lose a dime if its product injures people, even if those injuries are the result of negligent company practices, fraud or malice.
Some liability protection is warranted, but certainly not for fraud, gross negligence, mismanagement, failure to follow good manufacturing practices. Companies have no right to ask for indemnity for these things. ~ Lawrence Gostlin, Law Professor
Aside from Argentina and Brazil, nine other South American countries have reportedly negotiated deals with Pfizer. It’s unclear whether they actually ended up giving up national assets in return.2
Vaccine Maker Accused of Abusing Its Power
According to STAT News,3 “Legal experts have raised concerns that Pfizer’s demands amount to an abuse of power.” Lawrence Gostin, law professor at Georgetown University and director of the World Health Organization’s Collaborating Center on National and Global Health Law told STAT:4
“Pharmaceutical companies shouldn’t be using their power to limit lifesaving vaccines in low- and middle-income countries. [This] seems to be exactly what they’re doing … Some liability protection is warranted, but certainly not for fraud, gross negligence, mismanagement, failure to follow good manufacturing practices. Companies have no right to ask for indemnity for these things.”
Mark Eccleston-Turner, a lecturer in global health law at Keele University in England, added:5
“[Pfizer] is trying to eke out as much profit and minimize its risk at every juncture with this vaccine development then this vaccine rollout. Now, the vaccine development has been heavily subsidized already. So there’s very minimal risk for the manufacturer involved there.”
Don’t Expect Compensation if Injured by COVID-19 Vaccine
In the U.S., vaccine makers already enjoy full indemnity against injuries occurring from this or any other pandemic vaccine under the PREP Act. If you’re injured, you’d have to file a compensation claim with the Countermeasures Injury Compensation Program (CICP),6 which is funded by U.S. taxpayers via Congressional appropriation to the Department of Health and Human Services (DHHS).
While similar to the National Vaccine Injury Compensation Program (NVICP), which applies to nonpandemic vaccines, the CICP is even less generous when it comes to compensation. For example, while the NVICP pays some of the costs associated with any given claim, the CICP does not. This means you’ll also be responsible for attorney fees and expert witness fees.
A significant problem with the CICP is that it’s administered within the DHHS, which is also sponsoring the COVID-19 vaccination program. This conflict of interest makes the CICP less than likely to find fault with the vaccine.
Your only route of appeal is within the DHHS, where your case would simply be reviewed by another employee. The DHHS is also responsible for making the payment, so the DHHS effectively acts as judge, jury and defendant. As reported by Dr. Meryl Nass,7 the maximum payout you can receive — even in cases of permanent disability or death — is $250,000 per person; however, you’d have to exhaust your private insurance policy before the CICP gives you a dime.
CICP will only pay the difference between what your insurance covers and the total payout amount established for your case. For permanent disability, even $250,000 won’t go far. The CICP also has a one year statute of limitations, so you have to act quickly.
This too is a significant problem, as no one really knows what injuries might arise from the COVID-19 vaccine, or when, and this makes tying the injury to the vaccination a difficult prospect. Employers that mandate the COVID-19 vaccine will also be indemnified from liability for side effects. Instead, claims will be routed through worker’s compensation programs.
If the COVID-19 vaccines are as safe as the manufacturers claim, why do they insist on so much indemnification? Do they suspect or know something they’re refusing to admit publicly?
Side Effects Are Inevitable
Of course, those of us who have been looking at the science behind the mRNA technology used to create these novel “vaccines” have long since realized there are tremendous risks involved. For starters, mRNA vaccines are most accurately referred to as gene therapies, as this is what they are.
They effectively turn your cells into bioreactors that churn out viral proteins to incite an immune response, and there’s no off-switch.8 Based on historical and preliminary evidence, significant short- and long-term side effects are, quite frankly, inevitable.
For starters, your body sees the synthetic mRNA as “non-self,” which can cause autoantibodies to attack your own tissues. Judy Mikovits, Ph.D., explained this in her interview, featured in “How COVID-19 ‘Vaccines’ May Destroy the Lives of Millions.”
Free mRNA also drive inflammatory diseases, which is why making synthetic mRNA thermostable — i.e., slowing the breakdown of the RNA by encasing it in lipid nanoparticles — is likely to be problematic. The nanoparticles themselves also pose a risk. COVID-19 vaccines use PEGylated lipid nanoparticles, which is known to cause allergic reactions and anaphylaxis.9,10
What’s more, previous attempts to develop an mRNA-based drug using lipid nanoparticles failed and had to be abandoned because when the dose was too low, the drug had no effect, and when dosed too high, the drug became too toxic.11 An obvious question is: What has changed that now makes this technology safe enough for mass use?
As detailed in my interview with Mikovits, the synthetic RNA influences the gene syncytin, which can result in:
- Brain inflammation
- Dysregulated communication between the microglia in your brain, which are critical for clearing toxins and pathogens
- Dysregulated immune system
- Dysregulated endocannabinoid system (which calms inflammation)
Pathogenic Priming and Antibody-Dependent Enhancement
Another significant problem is that we don’t know whether antibody production is protective or pathogenic in coronavirus infections. If pathogenic, vaccinated individuals may be at increased risk of severe illness if they’re exposed to SARS-CoV-2 in the future. As reported in a December 11, 2020, Vaccine: X paper:12
“The first SARS-CoV-2 vaccine(s) will likely be licensed based on neutralizing antibodies in Phase 2 trials, but there are significant concerns about using antibody response in coronavirus infections as a sole metric of protective immunity.
Antibody response is often a poor marker of prior coronavirus infection, particularly in mild infections, and is shorter-lived than virus-reactive T-cells … Strong antibody response correlates with more severe clinical disease while T-cell response is correlated with less severe disease; and antibody-dependent enhancement of pathology and clinical severity has been described.
Indeed, it is unclear whether antibody production is protective or pathogenic in coronavirus infections. Early data with SARS-CoV-2 support these findings. Data from coronavirus infections in animals and humans emphasize the generation of a high-quality T cell response in protective immunity.”
A number of reports in the medical literature have indeed highlighted the risk of pathogenic priming and antibody-dependent enhancement (ADE). As explained in “Out of the Frying Pan and Into the Fire? Due Diligence Warranted for ADE in COVID-19”:13
“ADE is an immunological phenomenon whereby a previous immune response to a virus can render an individual more susceptible to a subsequent analogous infection.
Rather than viral recognition and clearance, the prior development of virus-specific antibodies at a non-neutralizing level can facilitate viral uptake, enhancing replication; a possible immune evasion strategy avoiding intracellular innate immune sensors, or pattern recognition receptors …
ADE of SARS-CoV has also been described14 through a novel FcγRII-dependent and ACE2-independent cell entry mechanism. The authors state15 that this warrants concern in the safety evaluation of any candidate human vaccines against SARS-CoV.”
Similarly, “Pathogenic Priming Likely Contributes to Serious and Critical Illness and Mortality in COVID-19 Via Autoimmunity,” published in the Journal of Translational Autoimmunity, warns that:16
“Failure of SARS and MERS vaccines in animal trials involved pathogenesis consistent with an immunological priming that could involve autoimmunity in lung tissues due to previous exposure to the SARS and MERS spike protein. Exposure pathogenesis to SARS-CoV-2 in COVID-19 likely will lead to similar outcomes.”
So, to be clear, what all of this means is that if you get vaccinated, you may actually be at increased risk for serious illness if/when you’re exposed to any number of mutated SARS-CoV-2 strains in the future.
This is why the recommendation to vaccinate individuals who have previously been infected with SARS-CoV-2, or who have an active SARS-CoV-2 infection, may actually be quite dangerous. Dr. Hooman Noorchashm recently sent a public letter17 to the U.S. Food and Drug Administration Commissioner detailing these risks.
How mRNA Injections May Trigger Prion Disease
What’s more, in a paper18 titled, “COVID-19 RNA Based Vaccines and the Risk of Prion Disease,” published in Microbiology & Infectious Diseases, Dr. Bart Classen warns there are also troubling evidences suggesting some of the mRNA shots may cause prion diseases such as Alzheimer’s and ALS. He writes:
“In the current paper, the concern is raised that the RNA based COVID vaccines have the potential to cause more disease than the epidemic of COVID-19. This paper focuses on a novel potential adverse event mechanism causing prion disease which could be even more common and debilitating than the viral infection the vaccine is designed to prevent …
Analysis of the Pfizer vaccine against COVID-19 identified two potential risk factors for inducing prion disease is humans. The RNA sequence in the vaccine contains sequences believed to induce TDP-43 and FUS to aggregate in their prion based conformation leading to the development of common neurodegerative diseases.
In particular it has been shown that RNA sequences GGUA, UG rich sequences, UG tandem repeats, and G Quadruplex sequences, have increased affinity to bind TDP-43 and or FUS and may cause TDP-43 or FUS to take their pathologic configurations in the cytoplasm.
In the current analysis a total of sixteen UG tandem repeats were identified and additional UG rich sequences were identified. Two GGΨA sequences were found. G Quadruplex sequences are possibly present but sophisticated computer programs are needed to verify these.
The spike protein encoded by the vaccine binds angiotensin converting enzyme 2 (ACE2), an enzyme which contains zinc molecules. The binding of spike protein to ACE2 has the potential to release the zinc molecule, an ion that causes TDP-43 to assume its pathologic prion transformation.”
mRNA Technology Has Potential to Cause Microvascular Injury
Additionally, Dr. J. Patrick Whelan, a pediatric rheumatologist specializing in multisystem inflammatory syndrome, submitted a public comment19 to the FDA back in December 2020, in which he expressed concern that mRNA vaccines have “the potential to cause microvascular injury to the brain, heart, liver and kidneys in ways that were not assessed in safety trials.”
He cited research showing that “the spike protein in brain endothelial cells is associated with formation of microthrombi (clots),” and that since no viral RNA has been found in brain endothelium, “viral proteins appear to cause tissue damage without actively replicating virus.”
“Is it possible the spike protein itself causes the tissue damage associated with Covid-19?” he asks. “In 13/13 brains from patients with fatal COVID-19, pseudovirions (spike, envelope, and membrane proteins) without viral RNA are present in the endothelia of cerebral microvessels …
It appears that the viral spike protein that is the target of the major SARS-CoV-2 vaccines is also one of the key agents causing the damage to distant organs that may include the brain, heart, lung, and kidney.
Before any of these vaccines are approved for widespread use in humans, it is important to assess in vaccinated subjects the effects of vaccination on the heart … Vaccinated patients could also be tested for distant tissue damage in deltoid area skin biopsies …”
Reports of Side Effects Are Rapidly Mounting
Around the world, reports are now pouring in of people dying shortly after receiving the COVID-19 vaccine. In many cases, they die suddenly within hours of getting the shot. In others, death occurs within the span of a couple of weeks.
In the wake of 29 senior citizen deaths,20 Norway is reportedly considering excluding the very old and terminally ill from getting the AstraZeneca vaccine. According to the Norwegian Medicines Agency:21
“Most people have experienced the expected side effects of the vaccine, such as nausea and vomiting, fever, local reactions at the injection site, and worsening of their underlying condition.”
The Norwegian Institute of Public Health further noted that “for those with the most severe frailty, even relatively mild vaccine side effects can have serious consequences,” and that “For those who have a very short remaining life span anyway, the benefit of the vaccine may be marginal or irrelevant.”22
For the most definitive protection of the entire family from the potential adverse effects of vaccinations, eliminate the risks and high costs of hospitalization, and help the body decisively cure itself from cancer, or any other conditions caused by any known and unknown type of viruses or bioweapons, try the electronic Virutron® PRO Full Spectrum Antiviral + CES System and worry no more...